Positions

Overview

  • Ricardo Azziz is an internationally recognized physician, scientist, and executive who currently serves as CEO of the American Society for Reproductive Medicine, the largest multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine worldwide. Previously he served as Chief Officer, Academic Health & Hospital Affairs, and Director of the SUNY Hispanic Leadership Institute, the State University of New York (SUNY), the largest university system in the nation. Dr. Azziz previously also served as president of Georgia Health Sciences University and then founding president of Georgia Regents University, one of Georgia’s four comprehensive research-level universities. He also served as founding CEO of the Georgia Regents Health System, the state’s only public academic health center.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunctionJournal of Clinical Endocrinology and Metabolism.  105. 2020
    2020 The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndromeReproductive BioMedicine Online.  41:734-742. 2020
    2020 Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations"Journal of Clinical Endocrinology and Metabolism.  105. 2020
    2020 Racial and ethnic differences in the metabolic response of polycystic ovary syndromeClinical Endocrinology.  93:163-172. 2020
    2020 Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell FunctionJournal of Clinical Endocrinology and Metabolism.  105. 2020
    2020 Environmental Pollutant Benzo[a]pyrene Induces Recurrent Pregnancy Loss through Promoting Apoptosis and Suppressing Migration of Extravillous TrophoblastBioMed Research International.  2020. 2020
    2019 Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: An androgen excess and PCOS society resourceHuman Reproduction.  34:2254-2265. 2019
    2019 Anti-Müllerian Hormone in PCOS: A Review Informing International GuidelinesTrends in Endocrinology and Metabolism.  30:467-478. 2019
    2019 Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non–insulin-mediated whole-body glucose uptakeClinical Endocrinology.  90:542-552. 2019
    2019 Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter…)Fertility and Sterility.  111:681-682. 2019
    2019 Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS CommitteeJournal of Clinical Endocrinology and Metabolism.  104:2875-2891. 2019
    2019 Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome—Based on liquid chromatography with tandem mass spectrometry measurementsJournal of Clinical Laboratory Analysis.  33. 2019
    2019 Complex diseases and co-morbidities: Polycystic ovary syndrome and type 2 diabetes mellitusEndocrine Connections.  8:R71-R75. 2019
    2019 Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndromeHuman Reproduction.  34:335-344. 2019
    2019 Is antimüllerian hormone an early marker or an in utero effector of incipient polycystic ovary syndrome?Fertility and Sterility.  111:264-265. 2019
    2019 Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndromeFertility and Sterility.  111:389-396. 2019
    2019 The pressing need for standardization in epidemiologic studies of PCOS across the globeGynecological Endocrinology.  35:1-3. 2019
    2019 Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndromeHuman Reproduction.  34:127-136. 2019
    2019 FSH beyond fertilityFrontiers in Endocrinology.  10. 2019
    2018 Why we need epidemiologic studies of polycystic ovary syndrome in Africa 2018
    2018 Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeClinical Endocrinology.  89:251-268. 2018
    2018 Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeFertility and Sterility.  110:364-379. 2018
    2018 Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary SyndromeJournal of Women's Health.  27:892-902. 2018
    2018 Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeHuman Reproduction.  33:1602-1618. 2018
    2018 Reproductive endocrinology and infertility: Clinical expert series polycystic ovary syndromeObstetrics and Gynecology.  132:321-336. 2018
    2017 Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?Fertility and Sterility.  108:959-960. 2017
    2017 Health System Creation and Integration at a Health Sciences University: A Five-Year Follow-upJournal of Healthcare Management.  62:386-402. 2017
    2017 Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)Clinical Chemistry and Laboratory Medicine.  55:1789-1797. 2017
    2017 Genetic basis of eugonadal and hypogonadal female reproductive disorders 2017
    2017 Letter to the Editor: "Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis"Journal of Clinical Endocrinology and Metabolism.  102:3865-3866. 2017
    2017 Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: An update with a special focus on adolescent and adult womenHuman Reproduction Update.  23:580-599. 2017
    2017 Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: A pilot studyJournal of Ovarian Research.  10. 2017
    2017 Genetics of polycystic ovary syndrome 2017
    2017 Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1 2017
    2017 PCOS: Animal models for PCOS-not the real thingNature Reviews Endocrinology.  13:382-384. 2017
    2017 Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell linesCancer Cell International.  17. 2017
    2017 Polycystic Ovarian Syndrome: Long-Term Health ConsequencesSeminars in Reproductive Medicine.  35:271-281. 2017
    2017 Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndromeHuman Reproduction.  32:185-192. 2017
    2017 Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?Journal of Clinical Endocrinology and Metabolism.  102:4421-4427. 2017
    2016 Androgen excess: Investigations and management 2016
    2016 Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysisFertility and Sterility.  106:1510-1520.e2. 2016
    2016 Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary SyndromeJournal of Women's Health.  25:875-881. 2016
    2016 Polycystic ovary syndromeNature Reviews Disease Primers.  2. 2016
    2016 Criteria, prevalence, and phenotypes of polycystic ovary syndromeFertility and Sterility.  106:6-15. 2016
    2016 Evolutionary determinants of polycystic ovary syndrome: part 2Fertility and Sterility.  106:42-47. 2016
    2016 Introduction: Determinants of polycystic ovary syndromeFertility and Sterility.  106:4-5. 2016
    2016 Erratum : PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (Nature Reviews Endocrinology (2016) 12 (7475)) DOI:10.1038/nrendo.2015.230)Nature Reviews Endocrinology.  12:183. 2016
    2016 Association study of androgen signaling pathway genes in polycystic ovary syndromeFertility and Sterility.  105:467-473.e4. 2016
    2016 PCOS in 2015: New insights into the genetics of polycystic ovary syndromeNature Reviews Endocrinology.  12:74. 2016
    2016 Stein and Leventhal: 80 years onAmerican Journal of Obstetrics and Gynecology.  214:247.e1-247.e11. 2016
    2015 Basal metabolic rate in women with PCOS compared to eumenorrheic controlsClinical Endocrinology.  83:384-388. 2015
    2015 Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populationsNature Communications.  7. 2015
    2015 Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populationsNature Communications.  6. 2015
    2015 Berberine inhibits the proliferation of human uterine leiomyoma cellsFertility and Sterility.  103:1098-1106. 2015
    2015 Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndromeJournal of Clinical and Translational Endocrinology.  2:99-104. 2015
    2015 DHEA, DHEAS and PCOS 2015
    2015 Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individualsJournal of Clinical Endocrinology and Metabolism.  100:E182-E186. 2015
    2015 Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et alJournal of Clinical Endocrinology and Metabolism.  100. 2015
    2015 MicroRNA-223 expression is upregulated in insulin resistant human adipose tissueJournal of Diabetes Research.  2015. 2015
    2015 Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease HeterogeneityPLoS Genetics.  11. 2015
    2014 Artist's statement: ParanoiaAcademic Medicine.  89:549. 2014
    2014 Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndromeHuman Reproduction.  29:1508-1517. 2014
    2014 Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS 2014
    2014 Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: A case-control studyBMC Endocrine Disorders.  14. 2014
    2014 Polycystic ovary syndrome: What's in a name?Journal of Clinical Endocrinology and Metabolism.  99:1142-1145. 2014
    2014 Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness the coronary artery risk development in young adults women's study 2014
    2014 Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteriaFertility and Sterility.  101. 2014
    2014 The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  99:E2754-E2761. 2014
    2014 What Is the Value and Role of Academic Medicine in the Life of Its University?Academic Medicine.  89:208-211. 2014
    2013 Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndromeBioMed Research International.  2013. 2013
    2013 The severity of menstrual dysfunction as a predictor of insulin resistance in pcosJournal of Clinical Endocrinology and Metabolism.  98. 2013
    2013 Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOSClinical Endocrinology.  79:550-557. 2013
    2013 Implementing a teaching service for voluntary faculty in obstetrics and gynecology: Long-term results 2013
    2013 Polycystic ovary syndrome, microbiomics and why you should be a little selfish with your timeExpert Review of Endocrinology and Metabolism.  8:329-331. 2013
    2013 Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  98. 2013
    2013 Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in femalesJournal of Clinical Endocrinology and Metabolism.  98:1541-1548. 2013
    2013 Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndromeFertility and Sterility.  99:599-604. 2013
    2013 Mirna-93 inhibits glut4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistanceDiabetes.  62:2278-2286. 2013
    2012 Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndromeObstetrical and Gynecological Survey.  67:707-709. 2012
    2012 Erratum: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis (Diabetologia DOI 10.1007/s00125-012-2638-6)Diabetologia.  55:2858-2859. 2012
    2012 Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis 2012
    2012 Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibilityJournal of Clinical Endocrinology and Metabolism.  97. 2012
    2012 Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage 2012
    2012 Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  97. 2012
    2012 Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS)Steroids.  77:317-322. 2012
    2012 Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohortsJournal of Medical Genetics.  49:90-95. 2012
    2012 A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause 2012
    2012 Identifying and Developing Leadership Competencies in Health Research Organizations: A Pilot Study. 2012
    2012 Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysisDiabetologia.  55:2636-2645. 2012
    2011 Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeysPLoS ONE.  6. 2011
    2011 Defining hirsutism in Chinese women: A cross-sectional studyFertility and Sterility.  96:792-796. 2011
    2011 New name, school still addressing physician shortages in Georgia.Journal of the Medical Association of Georgia.  100. 2011
    2011 Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndromeFertility and Sterility.  95. 2011
    2011 Congenital Adrenal HyperplasiaJournal of Pediatric and Adolescent Gynecology.  24:116-126. 2011
    2011 Harnessing expression data to identify novel candidate genes in polycystic ovary syndromePLoS ONE.  6. 2011
    2011 Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: Evidence of cell plasticityPLoS ONE.  6. 2011
    2011 Fifteen-year trend in the use of male reproductive surgery: Analysis of the healthcare cost and utilization project dataBJU International.  107:1118-1123. 2011
    2011 Polycystic ovary syndrome: An ancient disorder?Fertility and Sterility.  95:1544-1548. 2011
    2011 Polycystic ovary syndrome: Etiology, pathogenesis and diagnosisNature Reviews Endocrinology.  7:219-231. 2011
    2011 DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Obstetrical and Gynecological Survey.  66:143-144. 2011
    2011 Socioeconomic status and polycystic ovary syndromeJournal of Women's Health.  20:413-419. 2011
    2011 FTO and MC4R gene variants are associated with obesity in polycystic ovary syndromePLoS ONE.  6. 2011
    2011 Reanalyzing the modified Ferriman-Gallwey score: Is there a simpler method for assessing the extent of hirsutism?Fertility and Sterility.  96. 2011
    2011 Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndromeFertility and Sterility.  95. 2011
    2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160))Journal of Clinical Endocrinology and Metabolism.  95:5137. 2010
    2010 Evaluating professionalism, practice-based learning and improvement, and systems-based practice: utilization of a compliance form and correlation with conflict styles.Journal of graduate medical education.  2:423-429. 2010
    2010 Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS SocietyFertility and Sterility.  94:690-693. 2010
    2010 Response to Letter to the EditorMaturitas.  66:329-330. 2010
    2010 The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasiaFertility and Sterility.  94:684-689. 2010
    2010 Association study of four key folliculogenesis genes in polycystic ovary syndromeBJOG: An International Journal of Obstetrics and Gynaecology.  117:756-760. 2010
    2010 Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndromeDigestive Diseases and Sciences.  55:1085-1089. 2010
    2010 Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteriaFertility and Sterility.  93:1938-1941. 2010
    2010 Promoting residents' professional development and academic productivity using a structured faculty mentoring program 2010
    2010 Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple questionMaturitas.  65:297-298. 2010
    2010 The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument.Journal of graduate medical education.  2:118-125. 2010
    2010 A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. 2010
    2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guidelineJournal of Clinical Endocrinology and Metabolism.  95:4133-4160. 2010
    2010 DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Journal of Clinical Endocrinology and Metabolism.  95:4985-4992. 2010
    2010 Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylationFertility and Sterility.  94. 2010
    2010 Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. 2010
    2010 Nonclassic congenital adrenal hyperplasia. 2010
    2010 Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-αJournal of Clinical Endocrinology and Metabolism.  95:935-942. 2010
    2010 The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis studyJournal of Clinical Endocrinology and Metabolism.  95:4432-4440. 2010
    2010 Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndromeFertility and Sterility.  94. 2010
    2009 From the eye of the nurses: 360-degree evaluation of residentsJournal of Continuing Education in the Health Professions.  29:105-110. 2009
    2009 Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndromeEuropean Journal of Endocrinology.  161:405-409. 2009
    2009 A faculty and resident development program to improve learning and teaching skills.Journal of graduate medical education.  1:127-131. 2009
    2009 Total estrogen time and obstructive coronary disease in women: Insights fromthe NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Journal of Women's Health.  18:1315-1322. 2009
    2009 Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOSFertility and Sterility.  92:643-647. 2009
    2009 Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-h295r adrenocortical cell lineFertility and Sterility.  92:793-797. 2009
    2009 Fifteen-year trend in the use of reproductive surgery in women in the United StatesFertility and Sterility.  92:727-735. 2009
    2009 ReplyAmerican Journal of Obstetrics and Gynecology.  201. 2009
    2009 Reply of the Authors: Criteria for the polycystic ovary syndromeFertility and Sterility.  92. 2009
    2009 Visually scoring hirsutismHuman Reproduction Update.  16:51-64. 2009
    2009 Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cellsFertility and Sterility.  91:2551-2556. 2009
    2009 Reply of the Authors: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndromeFertility and Sterility.  91. 2009
    2009 Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndromeFertility and Sterility.  91:1848-1852. 2009
    2009 First evidence of genetic association between AKT2 and polycystic ovary syndrome (Diabetes Care (2008) 31, (2284-2287))Diabetes Care.  32:968. 2009
    2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertility and Sterility.  91:456-488. 2009
    2009 Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  94:3282-3288. 2009
    2009 Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase geneJournal of Clinical Endocrinology and Metabolism.  94:5034-5038. 2009
    2008 Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3Fertility and Sterility.  90:2291-2297. 2008
    2008 Use of metformin in polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology.  199:596-609. 2008
    2008 Effect of oral estrogen on substrate utilization in postmenopausal womenFertility and Sterility.  90:1275-1278. 2008
    2008 Metformin Use in Polycystic Ovary Syndrome: Metabolic Benefits and Diabetes PreventionAmerican Journal of Medicine.  121. 2008
    2008 Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndromeTherapeutics and Clinical Risk Management.  4:487-492. 2008
    2008 Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  93:2909-2912. 2008
    2008 Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  93:1939-1945. 2008
    2008 Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462))Human Reproduction.  23:1474. 2008
    2008 Diagnosing the diagnosis: Why we must standardize the defining features of polycystic ovary syndromeAnnals of Clinical Biochemistry.  45:3-5. 2008
    2008 FEM1A and FEM1B: Novel candidate genes for polycystic ovary syndromeHuman Reproduction.  23:2842-2849. 2008
    2008 First evidence of genetic association between AKT2 and polycystic ovary syndromeDiabetes Care.  31:2284-2287. 2008
    2008 Impact of obesity on the risk for polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  93:162-168. 2008
    2008 Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  93:300-303. 2008
    2008 Polycystic ovary syndrome is a family affairJournal of Clinical Endocrinology and Metabolism.  93:1579-1581. 2008
    2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluationJournal of Clinical Endocrinology and Metabolism.  93:1276-1284. 2008
    2008 Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart diseaseJournal of Clinical Endocrinology and Metabolism.  93:4268-4275. 2008
    2008 Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndromeHuman Reproduction.  23:1214-1219. 2008
    2008 Socioeconomic and Racial Predictors of Undergoing Laparoscopic Hysterectomy for Selected Benign Diseases: Analysis of 341 487 Hysterectomies 2008
    2007 The adrenal and polycystic ovary syndromeReviews in Endocrine and Metabolic Disorders.  8:331-342. 2007
    2007 Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndromeFertility and Sterility.  87:1473-1476. 2007
    2007 Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndromeFertility and Sterility.  87:862-869. 2007
    2007 Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters: CommentaryObstetrical and Gynecological Survey.  62:245-247. 2007
    2007 Diagnosis of polycystic ovary syndromeClinical Obstetrics and Gynecology.  50:168-177. 2007
    2007 Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white womenJournal of Clinical Endocrinology and Metabolism.  92:4730-4733. 2007
    2007 Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sistersAmerican Journal of Obstetrics and Gynecology.  196:398.e1-398.e6. 2007
    2007 Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  92:2659-2664. 2007
    2007 Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statementJournal of Clinical Endocrinology and Metabolism.  92:405-413. 2007
    2006 Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sistersFertility and Sterility.  86:1688-1693. 2006
    2006 Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005Fertility and Sterility.  86:1318-1320. 2006
    2006 Difference in dietary intake between women with polycystic ovary syndrome and healthy controlsFertility and Sterility.  86:411-417. 2006
    2006 Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulationFertility and Sterility.  86:484-486. 2006
    2006 A twenty-first century research agenda for polycystic ovary syndromeBest Practice and Research: Clinical Endocrinology and Metabolism.  20:331-336. 2006
    2006 Diagnosis, epidemiology, and genetics of the polycystic ovary syndromeBest Practice and Research: Clinical Endocrinology and Metabolism.  20:193-205. 2006
    2006 Family size in women with polycystic ovary syndromeFertility and Sterility.  85:1837-1839. 2006
    2006 PrefaceBest Practice and Research: Clinical Endocrinology and Metabolism.  20. 2006
    2006 Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutismJournal of Clinical Endocrinology and Metabolism.  91:1345-1350. 2006
    2006 Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are prematureJournal of Clinical Endocrinology and Metabolism.  91:781-785. 2006
    2006 How prevalent is metabolic syndrome in women with polycystic ovary syndrome?Nature Reviews Endocrinology.  2:132-133. 2006
    2006 Role of diet in the treatment of polycystic ovary syndromeFertility and Sterility.  85:679-688. 2006
    2006 Reply of the Author [2]Fertility and Sterility.  85:530. 2006
    2006 Diagnosis, phenotype, and prevalence of polycystic ovary syndromeFertility and Sterility.  86:S7. 2006
    2006 Disparate access: The disproportionality of African American students with disabilities across educational environmentsExceptional Children.  72:411-424. 2006
    2006 Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guidelineJournal of Clinical Endocrinology and Metabolism.  91:4237-4245. 2006
    2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  91:48-53. 2006
    2006 Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasiaJournal of Clinical Endocrinology and Metabolism.  91:3451-3456. 2006
    2006 Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected womenJournal of Clinical Endocrinology and Metabolism.  91:4085-4091. 2006
    2005 What's the best way to diagnose insulin resistance and hyperinsulinemia?Contemporary OB/GYN.  50:66-74. 2005
    2005 Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month studyJournal of Clinical Endocrinology and Metabolism.  90:6072-6076. 2005
    2005 Polycystic ovary syndrome in Mexican-Americans: Prevalence and association with the severity of insulin resistanceFertility and Sterility.  84:766-769. 2005
    2005 Health care-related economic burden of the polycystic ovary syndrome during the reproductive life SpanJournal of Clinical Endocrinology and Metabolism.  90:4650-4658. 2005
    2005 Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  90:4852-4857. 2005
    2005 Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroupsFertility and Sterility.  83:1717-1723. 2005
    2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)Clinical Endocrinology.  62:644-649. 2005
    2005 Diagnostic criteria for polycystic ovary syndrome: A reappraisalFertility and Sterility.  83:1343-1346. 2005
    2005 Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  90:66-71. 2005
    2005 Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excessFertility and Sterility.  83:371-375. 2005
    2005 Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessmentFertility and Sterility.  83:1454-1460. 2005
    2004 Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validatedJournal of Clinical Epidemiology.  57:1279-1287. 2004
    2004 The prevalence of androgen excess among patients with minimal unwanted hair growthAmerican Journal of Obstetrics and Gynecology.  191:1914-1920. 2004
    2004 Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndromeJournal of Clinical Endocrinology and Metabolism.  89:5558-5562. 2004
    2004 Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndromeFertility and Sterility.  82:973-975. 2004
    2004 Advances in the evaluation and treatment of unwanted hair growth 2004
    2004 Potential cofounders in the laparoscopic detection of endometriosis [12] (multiple letters)Fertility and Sterility.  81:1722-1723. 2004
    2004 The prevalence and features of the polycystic ovary syndrome in an unselected populationJournal of Clinical Endocrinology and Metabolism.  89:2745-2749. 2004
    2004 Androgen Excess in Women: Experience with over 1000 Consecutive PatientsJournal of Clinical Endocrinology and Metabolism.  89:453-462. 2004
    2004 Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excessFertility and Sterility.  81:126-131. 2004
    2004 Early adrenarche in normal prepubertal girls: A prospective longitudinal studyJournal of Pediatric Endocrinology and Metabolism.  17:1231-1237. 2004
    2004 Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndromeFertility and Sterility.  81:120-125. 2004
    2004 PCOS: A diagnostic challengeReproductive BioMedicine Online.  8:644-648. 2004
    2003 PCOS and normal menses: Another point of viewContemporary OB/GYN.  48:62. 2003
    2003 The effectiveness of the interview for predicting the presence of polycystic ovary syndromeGynecological Endocrinology.  17:449-454. 2003
    2003 Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with TroglitazoneJournal of Clinical Endocrinology and Metabolism.  88:5137-5144. 2003
    2003 Polycystic ovary syndrome and ovulation induction 2003
    2003 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia: The Great PretenderSeminars in Reproductive Medicine.  21:295-300. 2003
    2003 Androgen excess is the key element in polycystic ovary syndromeFertility and Sterility.  80:252-254. 2003
    2003 We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndromeFertility and Sterility.  80:264-265. 2003
    2003 The evaluation and management of hirsutism.Obstetrics and Gynecology.  101:995-1007. 2003
    2003 Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndromeFertility and Sterility.  79:932-937. 2003
    2003 Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrateFertility and Sterility.  80:1450-1453. 2003
    2003 The evaluation and management of hirsutismObstetrics and Gynecology.  101:995-1007. 2003
    2003 The role of the adrenal cortex in polycystic ovary syndromeInfertility and Reproductive Medicine Clinics of North America.  14:557-568. 2003
    2002 Adrenal androgens in the polycystic ovary syndrome 2002
    2002 Advances in the evaluation and treatment of unwanted hair growth 2002
    2002 Advances in the evaluation and treatment of unwanted hair growthContemporary OB/GYN.  47:98-106. 2002
    2002 Role of reproductive surgeons and the Society of Reproductive SurgeonsFertility and Sterility.  78:916-917. 2002
    2002 Exploring the relationship between PCOS and Type 2 diabetes mellitusReferences en Gynecologie Obstetrique.  9:29-33. 2002
    2002 Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signalingJournal of Clinical Endocrinology and Metabolism.  87:4085-4087. 2002
    2002 Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndromeFertility and Sterility.  77:1125-1127. 2002
    2002 Laser hair reduction in the hirsute patient: A critical assessmentHuman Reproduction Update.  8:169-181. 2002
    2002 Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulationFertility and Sterility.  77:750-753. 2002
    2002 Should employer-sponsored health insurance benefits be made public?Fertility and Sterility.  77:216-217. 2002
    2002 Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitusFertility and Sterility.  77:1095-1105. 2002
    2001 Troglitazone use in polycystic ovary syndrome [4]Journal of Clinical Endocrinology and Metabolism.  86:5090-5091. 2001
    2001 Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: Preliminary studiesFertility and Sterility.  76:730-735. 2001
    2001 Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormonesFertility and Sterility.  76:823-825. 2001
    2001 Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropinJournal of Clinical Endocrinology and Metabolism.  86:2513-2517. 2001
    2001 Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.Journal of Clinical Endocrinology and Metabolism.  86:2513-2517. 2001
    2001 Hyperandrogenemia in patients presenting with acneFertility and Sterility.  75:889-892. 2001
    2001 Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trialJournal of Clinical Endocrinology and Metabolism.  86:1626-1632. 2001
    2001 Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.Journal of Clinical Endocrinology and Metabolism.  86:1626-1632. 2001
    2001 Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOSFertility and Sterility.  75:53-58. 2001
    2001 Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndromeFertility and Sterility.  75:625-628. 2001
    2001 Facial and abdominal hair growth in hirsutism: A computerized evaluationJournal of The American Academy of Dermatology.  45:846-850. 2001
    2001 Infertility treatment before assisted reproductive techniques 2001
    2001 Ovarian hormones and adrenal androgens during a woman’s life spanJournal of The American Academy of Dermatology.  45:S105-S115. 2001
    2001 Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology.  185:1381-1387. 2001
    2001 The role of the adrenal cortex in polycystic ovary syndromeObstetrics and Gynecology Clinics of North America.  28:63-75. 2001
    2000 A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndromeFertility and Sterility.  74:1237-1240. 2000
    2000 Family history as a risk factor for the polycystic ovary syndromeJournal of Pediatric Endocrinology and Metabolism.  13:1303-1306. 2000
    2000 Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal womenJournal of Clinical Endocrinology and Metabolism.  85:48-54. 2000
    2000 Idiopathic hirsutism 2000
    2000 Examination of the chin or lower abdomen only for the prediction of hirsutismFertility and Sterility.  74:980-983. 2000
    2000 The time has come to simplify the evaluation of the hirsute patientFertility and Sterility.  74:870-872. 2000
    2000 Adrenocortical hyperresponsivity to adrenocorticotropic hormone: A mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasiaFertility and Sterility.  74:329-334. 2000
    2000 Idiopathic hirsutism. 2000
    2000 Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto RicoFertility and Sterility.  74:59-62. 2000
    2000 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter studyAmerican Journal of Obstetrics and Gynecology.  183:1468-1474. 2000
    2000 A multicenter study of women with nonclassical congenital adrenal hyperplasia: Relationship between genotype and phenotypeMolecular Genetics and Metabolism.  71:527-534. 2000
    2000 Adrenal androgen excess in the polycystic ovary syndromeEndocrinologist.  10:245-254. 2000
    1999 11β-Hydroxyandrostenedione and δ5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasiaFertility and Sterility.  72:996-1000. 1999
    1999 Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: A prospective studyFertility and Sterility.  72:915-925. 1999
    1999 Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists 1999
    1999 Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. 1999
    1999 Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin 1999
    1999 Adrenal androgen excess in hyperandrogenism: Relation to age and body massFertility and Sterility.  71:671-674. 1999
    1999 Impact of architectural disruption on adrenocortical steroidogenesis in vitro.Journal of Clinical Endocrinology and Metabolism.  84:1017-1021. 1999
    1999 Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.Journal of Clinical Endocrinology and Metabolism.  84:946-950. 1999
    1999 Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndromeFertility and Sterility.  71:436-438. 1999
    1999 Impact of architectural disruption on adrenocortical steroidogenesis in vitroJournal of Clinical Endocrinology and Metabolism.  84:1017-1021. 1999
    1999 Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate levelJournal of Clinical Endocrinology and Metabolism.  84:946-950. 1999
    1999 Prevalence of 3β-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excessAmerican Journal of Obstetrics and Gynecology.  181:596-600. 1999
    1999 Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: A populational studyGynecological Endocrinology.  13:394-400. 1999
    1998 Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axisJournal of Clinical Endocrinology and Metabolism.  83:2317-2323. 1998
    1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective studyJournal of Clinical Endocrinology and Metabolism.  83:3078-3082. 1998
    1998 Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)Journal of Clinical Endocrinology and Metabolism.  83:1976-1987. 1998
    1998 The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal womenJournal of Clinical Endocrinology and Metabolism.  83:519-524. 1998
    1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.Journal of Clinical Endocrinology and Metabolism.  83:3078-3082. 1998
    1998 Differential binding of and testosterone to SHBG: Relation to circulating estradiol levels 1998
    1998 Idiopathic hirsutism: An uncommon cause of hirsutism in AlabamaFertility and Sterility.  70:274-278. 1998
    1998 Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.Journal of Clinical Endocrinology and Metabolism.  83:2317-2323. 1998
    1998 Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).Journal of Clinical Endocrinology and Metabolism.  83:1976-1987. 1998
    1998 Measurement of total serum testosterone levels using commercially available kits: High degree of between-kit variabilityFertility and Sterility.  69:286-292. 1998
    1998 Identification and characterization of cytosolic sulfotransferases in normal human endometriumChemico-Biological Interactions.  109:329-339. 1998
    1998 The development of the polycystic ovary syndrome: Family history as a risk factorTrends in Endocrinology and Metabolism.  9:55-58. 1998
    1998 Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophyJournal of Clinical Endocrinology and Metabolism.  83:3219-3224. 1998
    1998 Effect of ovarian steroid production on adrenal steroidogenesis? [6] (multiple letters)Fertility and Sterility.  70:1187-1189. 1998
    1998 Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisalJournal of Endocrinological Investigation.  21:707-720. 1998
    1998 On the 'First International Symposium on the Developmental Aspects of Androgen Excess'Trends in Endocrinology and Metabolism.  9:45-46. 1998
    1998 Role of the ovary in the adrenal androgen excess of hyperandrogenic womenFertility and Sterility.  69:851-859. 1998
    1997 Evaluation of infertility: A cost effective approachReferences en Gynecologie Obstetrique.  5:315-320. 1997
    1997 CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β- hydroxylase deficiencyHuman Molecular Genetics.  6:1829-1834. 1997
    1997 Detection of CAH heterozygotes [5] (multiple letters)Fertility and Sterility.  68:182-184. 1997
    1997 Detection of CAH heterozygotes.Fertility and Sterility.  68. 1997
    1997 Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenismJournal of Clinical Endocrinology and Metabolism.  82:479-485. 1997
    1997 Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.Journal of Clinical Endocrinology and Metabolism.  82:479-485. 1997
    1997 Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndromeHuman Reproduction.  12:1138-1141. 1997
    1997 Nonclassic adrenal hyperplasia. 1997
    1997 Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory womenFertility and Sterility.  67:569-572. 1997
    1996 Demystifying fallacies surrounding nonclassic adrenal hyperplasiaContemporary OB/GYN.  41:109-131. 1996
    1996 The 21-hydroxylase-deficient adrenal hyperplasias: More than ACTH oversecretion 1996
    1996 Adrenal androgen production in response to adrenocorticotropin infusions in menEndocrine Research.  22:717-722. 1996
    1995 SEX-HORMONE RESPONSE AFTER RESISTIVE TRAINING IN HEALTHY OLDER WOMENThe FASEB Journal.  9:A995-A995. 1995
    1995 21-hydroxylase-deficient nonclassic adrenal hyperplasiaEndocrinologist.  5:297-303. 1995
    1995 Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulationJournal of Clinical Endocrinology and Metabolism.  80:400-405. 1995
    1995 Advances in the diagnosis and treatment of the hirsute patientCurrent Opinion in Obstetrics and Gynecology.  7:344-350. 1995
    1995 Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic womenAmerican Journal of Obstetrics and Gynecology.  172:1251-1256. 1995
    1995 Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized studyJournal of Clinical Endocrinology and Metabolism.  80:3406-3411. 1995
    1995 Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulationAmerican Journal of Obstetrics and Gynecology.  172:914-918. 1995
    1995 Training, certification, and credentialing in gynecologic operative endoscopyClinical Obstetrics and Gynecology.  38:313-318. 1995
    1994 delta 5-Androstene-3 beta,17 beta-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile.Fertility and Sterility.  62:321-326. 1994
    1994 Clinical review 56: nonclassic adrenal hyperplasia: Current conceptsJournal of Clinical Endocrinology and Metabolism.  78:810-815. 1994
    1994 Editor's formulation: Towards a working classification of androgen excess disorders 1994
    1994 Preface 1994
    1994 Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized womenJournal of Clinical Endocrinology and Metabolism.  79:1747-1751. 1994
    1994 The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: Therapeutic responseFertility and Sterility.  61:570-572. 1994
    1994 Δ5-Androstene-3β,17β-diol in healthy eumenorrheic women: Relationship to body mass and hormonal profileFertility and Sterility.  62:321-326. 1994
    1993 Preface 1993
    1993 Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasia 1993
    1993 Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II.Surgery, gynecology & obstetrics.  177:135-139. 1993
    1993 3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenismAmerican Journal of Obstetrics and Gynecology.  168:889-895. 1993
    1993 Adrenocortical dysfunction in androgen excess 1993
    1993 Credentialing for endoscopic surgery [5]Fertility and Sterility.  60:381-382. 1993
    1993 Editor's formulation - The late-onset adrenal hyperplasias: An example of molecular biology applied to the study of androgen excess disorders 1993
    1993 Fertility and infertility: Editorial overviewCurrent Opinion in Obstetrics and Gynecology.  5:225-227. 1993
    1993 Laparoscopic surgery for ectopic pregnancies: Technology assessment and public health implicationsFertility and Sterility.  59:487-498. 1993
    1993 Microsurgery alone or with INTERCEED absorbable adhesion barrier for pelvic sidewall adhesion re-formationSurgery, gynecology & obstetrics.  177:135-139. 1993
    1992 Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathologyFertility and Sterility.  58:302-306. 1992
    1992 Operative endoscopy: The pressing need for a structured training and credentialing processFertility and Sterility.  58:1100-1102. 1992
    1992 Pro-453 to ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency 1992
    1991 11 beta-hydroxylase deficiency in hyperandrogenism.Fertility and Sterility.  55:733-741. 1991
    1991 Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulationJournal of Clinical Endocrinology and Metabolism.  73:1327-1331. 1991
    1991 Adrenal androgens and reproductive aging in females 1991
    1991 Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic womenFertility and Sterility.  56:427-433. 1991
    1991 Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasiaFertility and Sterility.  56:142-144. 1991
    1991 No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian diseaseFertility and Sterility.  56:1179-1182. 1991
    1991 The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized womenJournal of Clinical Endocrinology and Metabolism.  72:1025-1030. 1991
    1991 When is late-onset adrenal hyperplasia not late-onset adrenal hyperplasia? 1991
    1990 Dexamethasone Receptor Levels in Palatal and Lung Fibroblasts of Adult A/J and C57BL/6J Mice: Relationship to Glucocorticoid-Induced Cleft Palate 1990
    1990 21-Hydroxylase deficiency in female hyperandrogenism: Screening and DiagnosisObstetrical and Gynecological Survey.  45:132-133. 1990
    1990 Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling timeJournal of Clinical Endocrinology and Metabolism.  70:1273-1279. 1990
    1990 Androgen-Insensitivity Syndrome: Long-Term Results of Surgical Vaginal CreationJournal of Gynecologic Surgery.  6:23-26. 1990
    1990 Dexamethasone receptor levels in palatal and lung fibroblasts of adult A/J and C57BL/6J mice: Relationship to glucocorticoid-induced cleft palate 1990
    1990 Late onset adrenal hyperplasia: Mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitousFertility and Sterility.  54:819-823. 1990
    1990 On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenismJournal of Clinical Endocrinology and Metabolism.  70:431-436. 1990
    1990 Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasiaAmerican Journal of Obstetrics and Gynecology.  162:633-638. 1990
    1989 21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and DiagnosisJournal of Clinical Endocrinology and Metabolism.  69:577-584. 1989
    1989 Adenomyosis: Current perspectivesObstetrics and Gynecology Clinics of North America.  16:221-235. 1989
    1989 Postoperative recuperation: Relation to the extent of endoscopic surgeryFertility and Sterility.  51:1061-1064. 1989
    1989 Reproductive endocrinologic alterations in female asymptomatic obesityFertility and Sterility.  52:703-725. 1989
    1989 The treatment of hyperandrogenism with oral contraceptives 1989
    1988 Acute myometritis and chorioamnionitis during cesarean section of asymptomatic womenAmerican Journal of Obstetrics and Gynecology.  159:1137-1139. 1988
    1988 The development and use of a standard symphysial-fundal height growth curve in the prediction of small for gestational age neonates 1988
    1987 Genital anomalies in childhoodClinical Obstetrics and Gynecology.  30:682-696. 1987
    1986 Adenomyosis in pregnancy. A review 1986
    1986 Congenital adrenal hyperplasia: Long-term results following vaginal reconstructionFertility and Sterility.  46:1011-1014. 1986
    1981 The Hispanic patient. 1981

    Chapter

    Year Title Altmetric
    2018 Polycystic ovary syndrome.  59-69. 2018
    2015 Presidential and Academic Health Center Leadership within the Modern University: Opportunities and Challenges.  13-21. 2015
    2012 Androgen excess disorders.  682-704. 2012
    2007 Adrenocortical dysfunction in polycystic ovary syndrome.  288-315. 2007
    2005 Endocrinology of the ovary.  391-403. 2005

    Research Overview

  • Dr. Azziz’s biomedical research focuses on the study of reproductive endocrinology and androgen excess disorders, including hirsutism, PCOS, and non-classic adrenal hyperplasia. He has published over 500 original peer-reviewed articles, book chapters, and reviews, and is consistently ranked one of America’s Top Doctors. He previously served as Deputy Director of the Clinical & Translational Sciences Institute and Assistant Dean for Clinical and Translational Sciences at UCLA; and Director of the Center for Androgen-Related Disorders at Cedars-Sinai Medical Center, Los Angeles. He is the founder and serves as Senior Executive Director of the Androgen Excess & PCOS Society. Among other advisory capacities, he served on multiple NIH committees, chaired the US FDA Advisory Board on Reproductive Health Drugs, and served on the oversight committee for the California Institute for Regenerative Medicine.
  • Teaching Overview

  • Dr Azziz serves as Research Professor, Dept. of Health Policy, Management and Behavior, School pf Public Health, University at Albany-SUNY; Professor, Dept of Obstetrics & Gynecology, School of Medicine, The University of Alabama at Birmingham; Clinical Professor, Dept. of Obstetrics & Gynecology, David Geffen School of Medicine, UCLA; and Fellow, Rockefeller Institute for Government.
  • Education And Training

  • Doctor of Medicine, Penn State College of Medicine/Penn State Milton S. Hershey Medical Center 1981
  • Georgetown University Medical Center Obstetrics & Gynecology, Residency 1985
  • Johns Hopkins University School of Medicine Obstetrics & Gynecology, Postdoctoral Fellowship 1987
  • Full Name

  • Ricardo Azziz